Clinical Trials in Detroit

Showing 7641-7660 of 19,719 trials

LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum for Girls 15-19

NCT03265314

Alternatives For Girls (AFG) is offering LeadHer as a gender-specific teen pregnancy prevention curriculum to girls between the ages of 14-19 years old who live in Wayne County, MI. The curriculum seeks to demonstrate that girls who participate in LeadHer will show increased rates of avoidance of unprotected sex, will show increased use of birth control and reduced rates of pregnancy. LeadHer will run over a 6-session period covering topics designed to prevent teen pregnancy and develop girls into leaders. The sessions will be co-led by youth (Peer Educators).

Teenage Pregnancy

Alternatives For Girls508 participantsStarted Aug 2017

Detroit, Michigan, United States

COMPLETEDPhase 3< 1 mile

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

This study looks at the safety and effectiveness of VIR-7831 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either VIR-7831 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H2.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)367 participantsStarted Dec 2020

Tucson, Arizona, United States • Tucson, Arizona, United States • Fresno, California, United States +102 more locations

LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum for Girls 15-19

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Find Trials by Condition in Detroit

Exparel for Postoperative Pain Management in Shoulder Surgery

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

Studying Students at Risk for COVID-19

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Synuclein-One Study

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)